This study aimed to investigate the effects of a nutraceutical composition on the expression of some genes involved in muscle cells and functioning in osteoblast cells. The effects of nutraceutical composition have been compared to the effects of atorvastatin, which induces muscle pain and elevated creatine phosphokinase (CPK) serum level when administered to patients. In particular, we analyzed the MyoD-1 gene, which is responsible for modulation of the CPK gene, which is a marker of muscle pain and damage

A nutraceutical composition decreases cpk levels in saos-2 cells and in patients with elevated serum levels of this enzyme / Ammendola, Sergio; Stoppoloni, Daniela; Di Loreto, Mario; SCOTTO D'ABUSCO, Anna. - In: JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION. - ISSN 0731-5724. - STAMPA. - 35:(2016), pp. 559-567. [10.1080/07315724.2015.1093972]

A nutraceutical composition decreases cpk levels in saos-2 cells and in patients with elevated serum levels of this enzyme

SCOTTO D'ABUSCO, ANNA
2016

Abstract

This study aimed to investigate the effects of a nutraceutical composition on the expression of some genes involved in muscle cells and functioning in osteoblast cells. The effects of nutraceutical composition have been compared to the effects of atorvastatin, which induces muscle pain and elevated creatine phosphokinase (CPK) serum level when administered to patients. In particular, we analyzed the MyoD-1 gene, which is responsible for modulation of the CPK gene, which is a marker of muscle pain and damage
2016
CPK; MyoD-1; energy production; muscle pain; nutraceuticals; osteoblast; medicine (miscellaneous); nutrition and dietetics
01 Pubblicazione su rivista::01a Articolo in rivista
A nutraceutical composition decreases cpk levels in saos-2 cells and in patients with elevated serum levels of this enzyme / Ammendola, Sergio; Stoppoloni, Daniela; Di Loreto, Mario; SCOTTO D'ABUSCO, Anna. - In: JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION. - ISSN 0731-5724. - STAMPA. - 35:(2016), pp. 559-567. [10.1080/07315724.2015.1093972]
File allegati a questo prodotto
File Dimensione Formato  
Ammendola_A Nutraceutical _2016

solo gestori archivio

Note: Articolo principale
Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 572.75 kB
Formato Adobe PDF
572.75 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/876715
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 3
social impact